IL6 and myocardial infarction: This causal view is supported by increased circulating levels of interleukin-6 in patients with heart disease, as well as increased cardiac expression of IL-6 in animal models of myocardial infarction, cardiac hypertrophy, and dilated cardiomyopathy [39,40,41,42].